New Guardians Against Diabetes?

A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.

Written byEd Yong
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Human T-cellWIKIPEDIA, NIAID/NIHOur bodies are protected by white blood cells called T-cells that detect and destroy infections, tumors, and other threats. But these watchmen are themselves watched by regulatory T-cells, which suppress the proliferation of other T-cells and prevent our immune systems from turning against our own bodies.

Now, a team of Australian scientists has discovered a new type of these suppressors that are distinguished by a protein called CD52, which they produce in large quantities and release. These “CD52hi cells” appear to play a key role in type 1 diabetes. In humans with the disease, these cells are rare and ineffective at suppressing other T-cells. Furthermore, depleting these cells in diabetes-prone mice quickly triggers the disease.

“We can’t claim yet that these cells are important for preventing diabetes in humans, but the evidence suggests that they are,” said Len Harrison from the Walter & Eliza Hall Institute of Medical Research in Australia, who led the research, published today (May 19) in Nature Immunology.

“This finding will assist in the development of targeted ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies